Aurentz Vincent insider trades: Arena Pharmaceuticals (ARNA) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Aurentz reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 16, 2021 | ARNA | ↓ Sell | 2,524 | $85.00 | $215K | Direct | Feb 18, 2021 (2d) |
| Jun 2, 2020 | ARNA | ↓ Sell | 25,000 | $65.00 | $1.6M | Direct | Jun 4, 2020 (2d) |
| Feb 5, 2020 | ARNA | ↓ Sell | 9,000 | $50.00 | $450K | Direct | Feb 7, 2020 (2d) |
| Sep 9, 2019 | ARNA | ↓ Sell | 65,000 | $50.72 | $3.3M | Direct | Sep 10, 2019 (1d) |
| Dec 17, 2015 | EPRS | ↑ Buy | 2,200 | $3.43 | $8K | Direct | Dec 21, 2015 (4d) |
| Dec 9, 2015 | EPRS | ↑ Buy | 2,800 | $3.85 | $11K | Purchased by Spouse | Dec 11, 2015 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Aurentz Vincent's insider trades
Aurentz Vincent is Executive VP and CBO at Arena Pharmaceuticals (ARNA). Since Dec 9, 2015, Aurentz has reported 2 open-market purchases worth $18K and 4 sales worth $5.6M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (16 filings), option exercises (6 filings), shares returned to the company (3 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ARNA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.